Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

150%

3 of 2 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02505867Not ApplicableTerminated

The Role of Sleep Disordered Breathing in Heart Failure Admissions

Role: lead

NCT00701441Completed

The Role of Oxidative Stress in the Cardiovascular Consequences of Sleep Apnea

Role: lead

NCT00701038Not ApplicableCompleted

Diagnosis and Treatment of Sleep Apnea in the Acute Exacerbation of Heart Failure

Role: lead

All 3 trials loaded